אוריליסה 150 מ"ג - Orilissa150 mg

× ×ª×× × ×ª×¨××¤×

×××¨×©×

××× ×× ×× × ××¡×¤××	×××¨××××¡× 200 ×"× - Orilissa 200 mg
×§×××¦× ×¤×¨××§××××××ª (ATC4)	H01CC Anti-gonadotropin-releasing hormones
××¨××× ×¤×¢×× (ATC5)	Â Elagolix AS SODIUM 150 MG âH01CC03
×¦××¨×ª ××ª×	×¤××× - PER OS
×¦××¨×ª ××× ××	××××××ª ××¦××¤××ª ×¤×××, FILM COATED TABLETS ××× ××¢×ª ××× ×× ××ª×¨ ×× ××¨×¢×× ××© ××××× ××ª ××ª×¨××¤× ×××ª×× ×××× ×× ××××××¥ ××¤× ×©×××¤××¢ ××¢××× ××¦×¨××
××ª××××	Orilissa is indicated for the management of moderate to severe pain associated with endometriosis.
×¢××× ××¨××¤× ×××××¨××ª ××¢×××	Â ×¢××× ××¨××¤× 17.03.2021 Â ××××¨× ××¢××× 26.04.2021 ××××¨× ××¢××× 17.03.2021 ××××¨× ××¢××× 21.05.2020

×¢××× ××¦×¨××	Â ×¢××× ××¦×¨×× ×¢××¨××ª 26.04.2021 ×¢××× ××¦×¨×× ×¢×¨×××ª - ÙØ´Ø±Ø© ÙÙÙØ³ØªÙÙÙ Ø¨Ø§ÙÙØºØ© Ø§ÙØ¹Ø±Ø¨ÙØ© 26.04.2021 ×¢××× ××¦×¨×× ×× ××××ª - Patient information leafletâ 26.04.2021

×¢×¨××× ×××××§××¨×¤×××	×¢×¨××× ×§×©××¨×× ×××××§××¨×¤×××
×××¨××××¡× 150 ×"× ×××××¨ ××©×¨× ×××¨××××ª

×××¤××© ××××¨××	××××¨×× ×-PubMed
××××¢ ××¨×©×ª	RxList WebMD Drugs.com
×©× ××¦×¨×	ABBVIE INC., USA
×©× ××¢× ××¨××©××	ABBVIE BIOPHARMACEUTICALS LTD, ISRAEL
×¨××©×××	×ª××¨×× ×××©×: 1/2019. ×¨××©××× ××ª××¨××:
×ª××¨×× ×¢×××× ×××¨××	18/06/2021

×ª××× ×ª ××¨×××

×ª××× ×ª ××¨×××

השינוי האחרון נעשה בֹ־1 בינואר 2026 ב־03:08